Terms: = Breast cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721
1796 results:
1. Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer.
Chen H; Chen M; Zeng B; Tang L; Nie Q; Jin X; Guo W; Chen L; Lin Y; Wang C; Fu F
Front Immunol; 2024; 15():1284579. PubMed ID: 38690279
[TBL] [Abstract] [Full Text] [Related]
2. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA DDX11-AS1 promotes cell growth, migration and invasion through regulating epithelial-mesenchymal transition in breast cancer.
Xi X; Yang F; Ding Z; Zhuang H; Yuan H
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):40-44. PubMed ID: 38678629
[TBL] [Abstract] [Full Text] [Related]
4. Novel Anti-tumor Strategy for breast cancer: Synergistic Role of Oleuropein with Paclitaxel Therapeutic in MCF-7 Cells.
Yılmaz G; Özdemir F
Anticancer Agents Med Chem; 2024; 24(3):224-234. PubMed ID: 38629155
[TBL] [Abstract] [Full Text] [Related]
5. Community cohesion looseness in gene networks reveals individualized drug targets and resistance.
Wang S; Lee D
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38622359
[TBL] [Abstract] [Full Text] [Related]
6. [Comparative immunohistochemistry study of different antibodies clones for detection of breast cancer markers (estrogen receptor, progesterone receptor, HER2/neu, Ki-67)].
Kalinin DV; Samoylova DV; Danilova NV; Germanovich NY; Kuznetsova OA; Zavalishina LE
Arkh Patol; 2024; 86(2):14-20. PubMed ID: 38591902
[TBL] [Abstract] [Full Text] [Related]
7. PDP1 promotes the progression of breast cancer through STAT3 pathway.
Wang Y; Dang H; Qiao H; Tian Y; Guan Q
Cell Biochem Funct; 2024 Apr; 42(3):e3994. PubMed ID: 38566355
[TBL] [Abstract] [Full Text] [Related]
8. PGR-kitLG signaling drives a tumor-mast cell regulatory feedback to modulate apoptosis of breast cancer cells.
Yang Z; Chen H; Yin S; Mo H; Chai F; Luo P; Li Y; Ma L; Yi Z; Sun Y; Chen Y; Wu J; Wang W; Yin T; Zhu J; Shi C; Zhang F
Cancer Lett; 2024 May; 589():216795. PubMed ID: 38556106
[TBL] [Abstract] [Full Text] [Related]
9. Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mTOR pathway.
Guo M; Liu M; Li W; Wang C; Zhang L; Zhang H
J Cancer Res Clin Oncol; 2024 Mar; 150(3):155. PubMed ID: 38526702
[TBL] [Abstract] [Full Text] [Related]
10. A metabolomics approach reveals metabolic disturbance of human cholangiocarcinoma cells after parthenolide treatment.
He Y; Yu Q; Ma X; Lv D; Wang H; Qiu W; Chen XF; Jiao Y; Liu Y
J Ethnopharmacol; 2024 Jun; 328():118075. PubMed ID: 38513779
[TBL] [Abstract] [Full Text] [Related]
11. High rate of high-risk human papillomavirus among benign and breast cancer patients in Ethiopia.
Belachew EB; Desta AF; Mulu A; Deneke DB; Tefera DA; Alemu A; Anberber E; Beshah D; Girma S; Sewasew DT; Tessema TS; Howe R
PLoS One; 2024; 19(3):e0298583. PubMed ID: 38507429
[TBL] [Abstract] [Full Text] [Related]
12. Correlation between S100A7 and immune characteristics, methylation, tumor stemness and tumor heterogeneity in pan-cancer and its role in chemotherapy resistance in breast cancer.
Li Y; Yang X; Jin T; Li Q; Li X; Ma L
Aging (Albany NY); 2024 Mar; 16(6):5581-5600. PubMed ID: 38499391
[TBL] [Abstract] [Full Text] [Related]
13. Moracin D suppresses cell growth and induces apoptosis via targeting the XIAP/PARP1 axis in pancreatic cancer.
Zhong X; Ke X; Yang H; Ye X; Li C; Pan J; Ran W; Wang F; Cui H
Phytomedicine; 2024 Jun; 128():155527. PubMed ID: 38489888
[TBL] [Abstract] [Full Text] [Related]
14. IFN‑γ induces apoptosis in gemcitabine‑resistant pancreatic cancer cells.
Kong X; Cheng D; Xu X; Zhang Y; Li X; Pan W
Mol Med Rep; 2024 May; 29(5):. PubMed ID: 38488034
[TBL] [Abstract] [Full Text] [Related]
15. breast cancer Molecular Subtyping in Practice: A Real-World Study of the APIS breast cancer Subtyping Assay in a Consecutive Series of breast Core Biopsies.
Di Palma S; Koliou P; Simonovic A; Costa D; Faulkes C; Kobutungi B; Paterson F; Horsnell JD; Pakzad F; Irvine T; Partlett P; Clayton E; Collins N
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473863
[TBL] [Abstract] [Full Text] [Related]
16. Serum exosomal miR-3662 down-regulates the expression of RBMS3 to promote malignant progression and gemcitabine resistance of breast cancer cells.
Li X; Chu X; Wang H; Xiang L; Yue X
Chem Biol Drug Des; 2024 Mar; 103(3):e14488. PubMed ID: 38472166
[TBL] [Abstract] [Full Text] [Related]
17. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract] [Full Text] [Related]
18. PKMYT1 Promotes Epithelial-Mesenchymal Transition Process in Triple-Negative breast cancer by Activating Notch Signaling.
Li B; Huang L; Ruan J
Rev Invest Clin; 2024; 76(1):45-59. PubMed ID: 38442372
[TBL] [Abstract] [Full Text] [Related]
19. The novel circRNA circ_0045881 inhibits cell proliferation and invasion by targeting mir-214-3p in triple-negative breast cancer.
Ren J; Chen W; Zhou Y; Sun J; Jiang G
BMC Cancer; 2024 Mar; 24(1):278. PubMed ID: 38429642
[TBL] [Abstract] [Full Text] [Related]
20. Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced breast cancer Receiving Palbociclib: Results From the TREnd Trial.
Migliaccio I; Romagnoli D; Galardi F; De Luca F; Biagioni C; Curigliano G; Criscitiello C; Minisini AM; Moretti E; Risi E; Guarducci C; Nardone A; Biganzoli L; Benelli M; Malorni L
JCO Precis Oncol; 2024 Feb; 8():e2300285. PubMed ID: 38427931
[TBL] [Abstract] [Full Text] [Related]
[Next]
